ORYZF Stock Oryzon Genomics SA (ORYZF, $1.57) was a top loser this quarter, falling -18.91%

GET DAILY SIGNALS

Get AI intraday signals

ORYZF - Oryzon Genomics SA

Loading...

Price: $1.565

Daily change: -$0.055 (-3.4%)

Daily volume: 687

3-month price change: -$0.365 (-18.91%)

Capitalization: $99M

Industry: Biotechnology

Oryzon Genomics SA (ORYZF, $1.57) was a top loser over the last three months, falling -1 to $1.57 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry for the 3-month period ending January 21, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.

ORYZF in downward trend: price dove below 50-day moving average on November 17, 2025

ORYZF moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend. In of 12 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ORYZF as a result. In of 16 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for ORYZF crossed bearishly below the 50-day moving average on November 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.003) is normal, around the industry mean (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (332.704).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORYZF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORYZF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.